Press release
Curetis to Hold Investor Conference Call with Webcast on U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge today
04 Apr 2018 10:54 CEST
Company Name
CURETIS
ISIN
NL0011509294
Connect_20180404__curetis_pr_conference_call_details_fda_clearance_en_approved.pdf
Connect_20180404_curetis_pr_conference_call_details_fda_clearance_de-approved.pdf